Avita Medical (RCEL) Stock: Buy, Sell, or Hold?
RCEL - Avita Medical, Inc. Common Stock
$11.67
-0.17 (-1.44%)
▼
5d:
+7.66%
30d:
+13.08%
90d:
+174.59%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When RCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: RCEL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: RCEL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: RCEL is currently trading at $11.67, which is considered extended relative to its 30-day fair value range of $10.06 to $11.22. From a valuation perspective, the stock is trading at a discount (Forward PE: -19.5) compared to its historical average (8.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RCEL is in a strong uptrend. Immediate support is located at $9.90, while resistance sits at $12.23.
Market Sentiment: RCEL scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RCEL is in a strong uptrend. Immediate support is located at $9.90, while resistance sits at $12.23.
Market Sentiment: RCEL scores 10/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.06 -
$11.22
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (10/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($12.15)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.06 -
$11.22
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.45
(12.4%)
Support & Resistance Levels
Support Level
$9.90
Resistance Level
$12.23
Current Trend
Strong Uptrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.50
Wall Street Target
$12.15
(+4.1%)
Revenue Growth (YoY)
17.8%
Profit Margin
-57.0%
PE vs Historical
-19.5 vs 8.0
CHEAP
Share & Embed Analysis
Last updated: September 29, 2026 7:44 AM ET
Data refreshes hourly during market hours. Next update: 8:44 AM
Data refreshes hourly during market hours. Next update: 8:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 64 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 72 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 55 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 54 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 50 HOLD |
